Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Bolsa de Madrid  >  FAES Farma SA    FAE   ES0134950F36

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Bolsa De Madrid
05/23/2017 05/24/2017 05/25/2017 05/26/2017 05/29/2017 Date
3.115(c) 3.18(c) 3.15(c) 3.15(c) 3.16 Last
460 206 481 501 474 234 255 876 248 517 Volume
+0.81% +2.09% -0.94% 0.00% +0.32% Change
More quotes
Financials (€)
Sales 2017 244 M
EBIT 2017 53,6 M
Net income 2017 -
Finance 2017 88,7 M
Yield 2017 1,44%
Sales 2018 256 M
EBIT 2018 58,5 M
Net income 2018 41,0 M
Finance 2018 114 M
Yield 2018 2,27%
P/E ratio 2017 18,69
P/E ratio 2018 17,57
EV / Sales2017 3,01x
EV / Sales2018 2,77x
Capitalization 824 M
More Financials
Company
Faes Farma SA engages in the manufacture, marketing, and research of pharmaceutical products and raw materials for pharmaceutical use. Its products are for allergies, antihypertensive, dermatological, diabetes, digestive, otorhinolaryngology, osteoarticular, respiratory, women's health, central... 
Sector
Pharmaceuticals
Calendar
06/12 | 01:00pmShareholder meeting
More about the company
Surperformance© ratings of FAES Farma SA
Trading Rating : Investor Rating :
More Ratings
Latest news on FAES FARMA SA
2016 FAES FARMA SA : Cash amount paid with the scrip issue offered as an alternative ..
2016 FAES FARMA SA : ex-dividend day for final dividend
2015 FAES FARMA SA : Cash amount paid with the scrip issue offered as an alternative ..
2015 FAES FARMA SA : ex-dividend day for final dividend
2015 FAES FARMA : Statement 05/18/2015 (39 k.). Faes Farma has licensed a pharmaceuti..
2015 FAES FARMA : Comunicado 05/01/2015 (59 k.). Dividendo flexible. Datos de cierre ..
2015 FAES FARMA SA : BONUS ISSUE: 1 new share for 50 existing shares
2015 FAES FARMA : Statement 02/27/2015 (81 k.). Faes Farma increases its net probit b..
2014 FAES FARMA SA : Cash amount paid with the scrip issue offered as an alternative ..
2014 FAES FARMA SA : Cash amount paid with the scrip issue offered as an alternative ..
More news
Sector news : Pharmaceuticals - NEC
05/29 WARREN BUFFETT : Warren Buffett takes 3 percent stake in Germany's Lanxess
05/29DJMERCK : Congo Approves Anti-Ebola Vaccine to Combat Outbreak in Remote Northeast
05/26DJSUN PHARMACEUTICAL INDUSTRIES : Pharma 4Q Profit Falls 13.6%
05/24 JOHNSON & JOHNSON : J&J settles drug manufacturing probe by U.S. states for $33 ..
05/24 FTSE edges up helped by M&S, but miners weigh
More sector news : Pharmaceuticals - NEC
Latest Tweets
2015#Spain: Faes Farma : #Market Analysts predicted Oct 2015 sales growth & p.. 
2015#Frankfurt #stocks: Faes Farma : #Merger #Acquisition Analysts say: soft Aug .. 
2015Faes Farma desembarca en China mediante una 'joint venture' con Eddingpharm  
2015BRIEF-Faes Farma reaches license agreement for its product in USA  
2015#Frankfurt #stocks: Faes Farma : #Market Analysts conclude meagre sales profi.. 
More tweets
Qtime:5
Advertisement
Chart FAES FARMA SA
Duration : Period :
FAES Farma SA Technical Analysis Chart | FAE | ES0134950F36 | 4-Traders
Full-screen chart
Technical analysis trends FAES FARMA SA
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 6
Average target price 3,35 €
Spread / Average Target 6,4%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Gonzalo López Casanueva Co-Managing Director
Francisco Quintanilla Guerra Co-Managing Director
Mariano Ucar Angulo Chairman
Valentín Ruiz Unamunzaga Deputy MD & Director-Corporate Finance
Isidro Hermo Blanco Manager-Pharmaceutical Technology
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
FAES FARMA SA-6.25%921
JOHNSON & JOHNSON10.16%341 901
ROCHE HOLDING LTD.14.62%236 581
NOVARTIS AG6.07%211 457
PFIZER INC.-1.05%191 398
MERCK & CO., INC.10.28%177 567
More Results